LFG
LENZ

Larson Financial Group’s LENZ Therapeutics LENZ Stock Holding History

Larson Financial Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17K Buy
734
+677
+1,188% +$5.46K ﹤0.01% 2850
2026
Q1 		$522 Buy
57
+44
+338% +$618 ﹤0.01% 3309
2025
Q4 		$208 Sell
13
-165
-93% -$4.81K ﹤0.01% 3265
2025
Q3 		$8.29K Buy
178
+18
+11% +$662 ﹤0.01% 2113
2025
Q2 		$4.69K Buy
160
+121
+310% +$3.29K ﹤0.01% 2095
2025
Q1 		$1K Buy
+39
New +$960 ﹤0.01% 2389

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Larson Financial Group's LENZ Position: Q2 2026 in Review

Larson Financial Group increased its LENZ Therapeutics (LENZ) stake by 1,188% in Q2 2026, buying an estimated $5.46K and bringing the position to 734 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

Larson Financial Group first reported a position in LENZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.29K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Larson Financial Group held 734 shares of LENZ Therapeutics worth $4.17K as of Q2 2026.
  • Larson Financial Group bought 677 LENZ Therapeutics shares in Q2 2026, an estimated $5.46K.
  • LENZ Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2850 holding.
  • Larson Financial Group first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's LENZ Therapeutics position peaked at $8.29K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.